Moreover, co-administration of α-CD155 mitigated the severe GvHD effects observed with α-CD276 alone, as mortality in the α-CD155-treated groups was comparable to that of untreated humanized mice (Figure 2D). Here, CD276 is linked to graft versus host disease.